Emergence and dissemination of multi-resistant Gram negative Enterobacteriaceae: lessons to be learnt from local and national surveillance programs in Belgium

References

• Poirel L, Decousser JW, Nordmann P. Insertion sequence ISEcp1B is involved in expression and mobilization of a blaCTX-M β-lactamase gene. Antimicrob Agents Chemother. 2003;47(9):2938–45.
   PubMed Web of Science ®Google Scholar
• Canton R, Coque T, Baquero F. Multi-resistant Gram-negative bacilli: from epidemics to endemics. Curr Opin Infect Dis. 2003;16:315–25.
   PubMed Web of Science ®Google Scholar
• Vuye A, Verschraegen G, Claeys G. Plasmid-mediated β-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli resistant to ceftazidime. Antimicrob Agents Chemother. 1989;33(5):757–61.
   PubMed Web of Science ®Google Scholar
• Gori A, Espinasse F, Deplano A, Nonhoff C, Nicolas MH, Struelens MJ. Comparison of pulsed-field gel electrophoresis and randomly amplified DNA polymorphism analysis for typing extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae. J Clin Microbiol. 1996;34(10):2448–53.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Villalobos H, Malaviolle V, Frankard J, De Mendonça R, Nonhoff C, Deplano A, et al. Emergence of CTX-M extended spectrum b-lactamase-producing Escherichia coli in Belgium. Eurosurveillance Weekly 2005;10 (8). Available from: http://www.eurosurveillance.org
   Google Scholar
• Laurent C, Rodriguez-Villalobos H, Rost F, Strale H, Vincent JL, Deplano A, et al. Intensive care unit outbreak of extended-spectrum β-lactamase-producing Klebsiella pneumoniae controlled by cohorting patients and reinforcing infection control measures. Infect control Hosp Epidemiol. 2008;29(6):517–24.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Villalobos H, Bogaerts P, Berhin C, Bauraing C, Deplano A, Montesinos I, et al. Trends in production of extended-spectrum β-lactamases among enterobacteriaceae of clinical interest: results of a nationwide survey in Belgian hospitals. J Antimicrob Chemother. 2011;66(1):37–47.
   PubMed Web of Science ®Google Scholar
• Montesinos I, Rodriguez-Villalobos H, de Menonça R, Bogaerts P, Deplano A, Glupczynski Y. Molecular characterization of plasmids encoding CTX-M-15 extended-spectrum β-lactamase associated with the ST131 Escherichia coli clone in Belgium. J Antimicrob Chemother. 2010;65:1828–30.
   PubMed Web of Science ®Google Scholar
• Bertrand S, Weill FX, Cloeckaert A, Vrints M, Mairiaux E, Praud K, et al. Clonal emergence of extended-spectrum β-lactamase (CTX-M-2)-producing Salmonella enterica Serovar virchow isolates with reduced susceptibilities to ciprofloxacin among poultry and humans in Belgium and France (2000 to 2003). J Clin Microbiol. 2006;44(8):2897–903.
   PubMed Web of Science ®Google Scholar
• Deplano A, Rodriguez-Villalobos H, Glupczynski Y, Bogaerts P, Allemeersch D, Grimmelprez A, et al. Emerge and dissemination of multidrug resistant clones of pseudomonas aeruginosa producing VIM-2 metallo-beta-lactamase in Belgium. Euro Surveill. 2007;12(1):E070118.2.
   PubMedGoogle Scholar
• Bogaerts P, Montesinos I, Rodriguez-Villalobos H, Blairon L, Deplano A, Glupczynski Y. Emergence of clonally related Klebsiella pneumoniae isolates of sequence type 258 producing KPC-2 carbapenemase in Belgium. J Antimicrob Chemother. 2010;65:361–76.
   PubMed Web of Science ®Google Scholar
• Huang TD, Berhin C, Bogaerts P, Glupczynski Y; on behalf of a multicentre study group.Prevalence and mechanisms of resistance to carbapenems in Enterobacteriaceae isolates from 24 hospitals in Belgium. J Antimicrob Chemother. 2013;68(8):1832–7.
   PubMed Web of Science ®Google Scholar
• Livermore DM, Andrews JM, Hawkey PM, Ho PL, Keness Y, Doi Y, et al. Are susceptibility tests enough, or should laboratories still seek ESBLs and carbapenemases directly? J Antimicrob Chemother. 2012;67(7):1569–77.
   PubMed Web of Science ®Google Scholar
• Peirano G, Schreckenberger PC, Pitout JD. The characteristics of NDM-1- producing Escherichia coli that belong to the successful and virulent clone ST131. Antimicrob Agents Chemother. 2011;55(6):2986–8.
   PubMed Web of Science ®Google Scholar
• Morris D, McGarry E, Cotter M, Passet V, Lynch M, Ludden C, et al. Detection of OXA-48 carbapenemase in the pandemic clone Escherichia coli O25b:H4-ST131 in the course of investigation of an outbreak of OXA-48-producing Klebsiella pneumoniae. Antimicrob Agents Chemother. 2012;56(7):4030–1.
   PubMed Web of Science ®Google Scholar
• Morris D, Boyle F, Ludden C, Condon I, Hale J, O’Connell N, et al. Production of KPC-2 carbapenemase by an Escherichia coli clinical isolate belonging to the international ST131 clone. Antimicrob Agents Chemother. 2011;55(10):4935–6.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Baño J, Navarro MD, Retamar P, Picon E, Pascual A, Extended-spectrum beta-lactamases–red Española de Investigacion en Patología Infecciosa/Grupo de Estudio de Infeccion Hospitalaria Group. β-Lactam/β-Lactam inhibitor combinations for the treatment of bacteremia due to extended-spectrum β-lactamase–producing Escherichia coli: A post hoc analysis of prospective cohorts. Clin Infect Dis. 2012;54:167–74.
   PubMed Web of Science ®Google Scholar
• Stachyra T, Levasseur P, Péchereau MC, Girard AM, Claudon M, Miossec C, et al. In vitro activity of the b-lactam inhibitor NXL 104 againts KPC-2 carbapenemase and Enterobacteriaceae expressing KPC carbapenemases. J Antimicrob Chemother. 2009;64(2):326–9.
   PubMed Web of Science ®Google Scholar
• Lucasti C, Popescu I, Ramesh M, Lipka JCS. Comparative study of the efficacy and safety of ceftazidime/avibactam plus metronidazole versus meropenem in the treatment of complicated intra-abdominal infections in hospitalized adults: results of a randomized, double-blind, Phase II trial. J Antimicrob Chemother. 2013;68(5):1183–92.
   PubMed Web of Science ®Google Scholar
• Goosens H, Coenen S, Costers M, De Corte S, Sutter De, Gordts B, et al. Achievements of the Belgian antibiotic policy coordination commitee (BAPCCOC). Eurosurveillance. 2008;13(46). Available from: http://www.eurosurveillance.org
   Google Scholar
• Van Gastel E, Costers M, Peetermans WE, Struelens MJ. Nationwide implementation of antibiotic management teams in Belgian hospitals: a self-reporting survey. J Antimicrob Chemother. 2010;65:576–80
   PubMed Web of Science ®Google Scholar
• Jans B, Denis O, Glupczynski Y. Surveillances de bactéries résistantes aux antibiotiques dans les hôpitaux Belges (MRSA, VRE, BLSE+, CPE+ et A. baumannii-MR et P. aeruginosa-MR): année 2011. Brussels: Institut Scientifique de Santé Publique 2011. Available from: http://www.iph.fgov.be/nsih/surv_mrsa/download_fr.asp
   Google Scholar
• Cornaglia G, Hryniewicz W, Jarlier V, Kahlmeter G, Mittermayer H, Stratchounski L, et al. European recommendations for antimicrobial resistance surveillance. Clin Microbiol Infect. 2004;10(4):349–83.
   PubMed Web of Science ®Google Scholar